Literature DB >> 29475371

Surgical treatments for essential tremor.

Rodger J Elble1, Ludy Shih2, Jeffrey W Cozzens1.   

Abstract

INTRODUCTION: Essential tremor is the most common form of pathologic tremor. Surgical therapies disrupt tremorogenic oscillation in the cerebellothalamocortical pathway and are capable of abolishing severe tremor that is refractory to available pharmacotherapies. Surgical methods are raspidly improving and are the subject of this review. Areas covered: A PubMed search on 18 January 2018 using the query essential tremor AND surgery produced 839 abstracts. 379 papers were selected for review of the methods, efficacy, safety and expense of stereotactic deep brain stimulation (DBS), stereotactic radiosurgery (SRS), focused ultrasound (FUS) ablation, and radiofrequency ablation of the cerebellothalamocortical pathway. Expert commentary: DBS and SRS, FUS and radiofrequency ablations are capable of reducing upper extremity tremor by more than 80% and are far more effective than any available drug. The main research questions at this time are: 1) the relative safety, efficacy, and expense of DBS, SRS, and FUS performed unilaterally and bilaterally; 2) the relative safety and efficacy of thalamic versus subthalamic targeting; 3) the relative safety and efficacy of atlas-based versus direct imaging tractography-based anatomical targeting; and 4) the need for intraoperative microelectrode recordings and macroelectrode stimulation in awake patients to identify the optimum anatomical target. Randomized controlled trials are needed.

Entities:  

Keywords:  Essential tremor; deep brain stimulation; focused ultrasound; functional neurosurgery; stereotactic radiosurgery; thalamotomy

Mesh:

Year:  2018        PMID: 29475371     DOI: 10.1080/14737175.2018.1445526

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  12 in total

1.  Mapping tracts in the human subthalamic area by 11.7T ex vivo diffusion tensor imaging.

Authors:  Kenichi Oishi; Susumu Mori; Juan C Troncoso; Frederick A Lenz
Journal:  Brain Struct Funct       Date:  2020-04-17       Impact factor: 3.270

2.  Neuropsychological outcomes after thalamic deep brain stimulation for essential tremor.

Authors:  Kaltra Dhima; Julia Biars; Efstathios Kondylis; Sean Nagel; Xin Xin Yu; Darlene P Floden
Journal:  Parkinsonism Relat Disord       Date:  2021-10-27       Impact factor: 4.891

3.  Botulinum Toxin for the Treatment of Hand Tremor.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2018-07-19       Impact factor: 4.546

4.  Estimating Change in Tremor Amplitude Using Clinical Ratings: Recommendations for Clinical Trials.

Authors:  Rodger J Elble
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-10-11

5.  Essential tremor amplitude modulation by median nerve stimulation.

Authors:  Carolina Reis; Beatriz S Arruda; Alek Pogosyan; Peter Brown; Hayriye Cagnan
Journal:  Sci Rep       Date:  2021-09-06       Impact factor: 4.379

Review 6.  Parameters for subthalamic deep brain stimulation in patients with dystonia: a systematic review.

Authors:  Yuhan Wang; Chencheng Zhang; Bomin Sun; Dianyou Li; Yiwen Wu
Journal:  J Neurol       Date:  2021-01-01       Impact factor: 4.849

Review 7.  Medical Devices for Tremor Suppression: Current Status and Future Directions.

Authors:  Jiancheng Mo; Ronny Priefer
Journal:  Biosensors (Basel)       Date:  2021-03-30

Review 8.  The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models.

Authors:  Barbara Kosmowska; Jadwiga Wardas
Journal:  Biomolecules       Date:  2021-12-02

Review 9.  Managing Essential Tremor.

Authors:  Franziska Hopfner; Günther Deuschl
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088

Review 10.  Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders.

Authors:  Saravanan Subramaniam; David T Blake; Christos Constantinidis
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.